Story thread · 2 reports / 1 sources
ProMIS Neurosciences at Moody Capital conference: safety sets it apart
investing.com · 4d
First report: ProMIS Neurosciences at Cantor conference: Alzheimer’s drug gains focus — investing.com, 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.